Twist Bioscience Corporation TWST Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's operating cash flow?
- Twist Bioscience Corporation (TWST) reported operating cash flow of -$17.56M in Q1 2026.
- How has Twist Bioscience Corporation's operating cash flow changed year-over-year?
- Twist Bioscience Corporation's operating cash flow decreased by 35.2% year-over-year, from -$12.99M to -$17.56M.
- What is the long-term trend for Twist Bioscience Corporation's operating cash flow?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's operating cash flow has grown at a -19.3% compound annual growth rate (CAGR), from -$112.24M to -$47.63M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.